


Healthcare News Roundup: Biopharmaceutical
HSMN NewsFeed - 10 Sep 2015
Agilis Biotherapeutics Appoints Arthur Tzianabos, Ph.D., to the Board of Directors
Agilis Biotherapeutics Appoints Arthur Tzianabos, Ph.D., to the Board of Directors
HSMN NewsFeed - 10 Sep 2015
Protagonist Therapeutics Names Richard S. Shames, M.D. as Chief Medical Officer
Protagonist Therapeutics Names Richard S. Shames, M.D. as Chief Medical Officer
HSMN NewsFeed - 8 Sep 2015
Vanda Pharmaceuticals Announces the Appointment of European General Manager
Vanda Pharmaceuticals Announces the Appointment of European General Manager
HSMN NewsFeed - 31 Aug 2015
The Medicines Company Appoints Dr. Fred Eshelman as Non-Executive Chairman of the Board
The Medicines Company Appoints Dr. Fred Eshelman as Non-Executive Chairman of the Board
HSMN NewsFeed - 31 Aug 2015
FDA Grants Priority Review for Intercept's Obeticholic Acid for the Treatment of Primary Biliary Cirrhosis
FDA Grants Priority Review for Intercept's Obeticholic Acid for the Treatment of Primary Biliary Cirrhosis
HSMN NewsFeed - 28 Aug 2015
Perrigo Confident Its Shareholders Will Reject Mylan's Value Destructive Transaction
Perrigo Confident Its Shareholders Will Reject Mylan's Value Destructive Transaction
HSMN NewsFeed - 28 Aug 2015
Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo
Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo
HSMN NewsFeed - 27 Aug 2015
Immuno-Oncology Veteran Rachel Humphrey, M.D., Joins CytomX as Chief Medical Officer
Immuno-Oncology Veteran Rachel Humphrey, M.D., Joins CytomX as Chief Medical Officer
HSMN NewsFeed - 26 Aug 2015
Adare Pharmaceuticals Appoints Joseph Del Buono as Vice President, Finance and Chief Financial Officer
Adare Pharmaceuticals Appoints Joseph Del Buono as Vice President, Finance and Chief Financial Officer
HSMN NewsFeed - 25 Aug 2015
Regulus Appoints Michael Huang, M.D. as Vice President, Clinical Development
Regulus Appoints Michael Huang, M.D. as Vice President, Clinical Development
HSMN NewsFeed - 25 Aug 2015
Panther Biotechnology, Inc. Announces $1.215 Million Financing With Chicago Venture Partners
Panther Biotechnology, Inc. Announces $1.215 Million Financing With Chicago Venture Partners
HSMN NewsFeed - 24 Aug 2015
Chiasma Appoints William H. Ludlam, M.D., Ph.D., as Vice President of Medical Affairs
Chiasma Appoints William H. Ludlam, M.D., Ph.D., as Vice President of Medical Affairs
HSMN NewsFeed - 24 Aug 2015
Celator(R) Pharmaceuticals Appoints Michael R. Dougherty as Executive Chairman of Board of Directors
Celator(R) Pharmaceuticals Appoints Michael R. Dougherty as Executive Chairman of Board of Directors
HSMN NewsFeed - 24 Aug 2015
Pfizer Receives Clearance from U.S. Federal Trade Commission for Hospira Acquisition
Pfizer Receives Clearance from U.S. Federal Trade Commission for Hospira Acquisition
HSMN NewsFeed - 20 Aug 2015
Alder BioPharmaceuticals Appoints Paul B. Cleveland to Board of Directors
Alder BioPharmaceuticals Appoints Paul B. Cleveland to Board of Directors
HSMN NewsFeed - 20 Aug 2015
S1 Biopharma Supports FDA Approval of First-Ever Treatment for Hypoactive Sexual Desire Disorder
S1 Biopharma Supports FDA Approval of First-Ever Treatment for Hypoactive Sexual Desire Disorder
HSMN NewsFeed - 18 Aug 2015
Radius Health Announced That it Has Appointed Catherine Friedman to the Board of Directors
Radius Health Announced That it Has Appointed Catherine Friedman to the Board of Directors
HSMN NewsFeed - 14 Aug 2015
Pfizer Granted Approval From The Canadian Competition Bureau For Hospira Acquisition
Pfizer Granted Approval From The Canadian Competition Bureau For Hospira Acquisition
HSMN NewsFeed - 13 Aug 2015
Innocoll AG Appoints Rich Fante as Chief Commercial Officer and Head of Business Development
Innocoll AG Appoints Rich Fante as Chief Commercial Officer and Head of Business Development
HSMN NewsFeed - 11 Aug 2015
Ovid Therapeutics Completes Oversubscribed $75 Million Series B Financing
Ovid Therapeutics Completes Oversubscribed $75 Million Series B Financing
HSMN NewsFeed - 10 Aug 2015
Aratana Therapeutics Elects Wendy Yarno as Chairman of the Board of Directors
Aratana Therapeutics Elects Wendy Yarno as Chairman of the Board of Directors
HSMN NewsFeed - 10 Aug 2015
Chiasma Expands Management Team with Announcement of Anand Varadan as Chief Commercial Officer
Chiasma Expands Management Team with Announcement of Anand Varadan as Chief Commercial Officer
HSMN NewsFeed - 5 Aug 2015
Ohr Pharmaceutical Promotes Jason S. Slakter, MD to Chief Executive Officer
Ohr Pharmaceutical Promotes Jason S. Slakter, MD to Chief Executive Officer
HSMN NewsFeed - 5 Aug 2015
Mirati Therapeutics And MedImmune Partner On Immuno-Oncology Combination In Lung Cancer
Mirati Therapeutics And MedImmune Partner On Immuno-Oncology Combination In Lung Cancer
HSMN NewsFeed - 4 Aug 2015
Trigemina Appoints Dr. Shashi Kori to the Position of Chief Medical Officer
Trigemina Appoints Dr. Shashi Kori to the Position of Chief Medical Officer
HSMN NewsFeed - 3 Aug 2015
Omidria(R) Approved for Commercialization Throughout the European Union and Additional Countries
Omidria(R) Approved for Commercialization Throughout the European Union and Additional Countries
HSMN NewsFeed - 30 Jul 2015
Flexpoint Ford Announces Partnership with Alan MacKenzie and Bryan Stuart to Form Kastle Therapeutics
Flexpoint Ford Announces Partnership with Alan MacKenzie and Bryan Stuart to Form Kastle Therapeutics
HSMN NewsFeed - 29 Jul 2015
Unum Therapeutics Names Geoffrey Hodge as Senior Vice President, Operations
Unum Therapeutics Names Geoffrey Hodge as Senior Vice President, Operations
HSMN NewsFeed - 23 Jul 2015
RaNA Therapeutics Secures $55 Million in Oversubscribed Series B Financing
RaNA Therapeutics Secures $55 Million in Oversubscribed Series B Financing
HSMN NewsFeed - 22 Jul 2015
Wilson Therapeutics Announces the Appointment of Dr. Carl Bjartmar as Chief Medical Officer
Wilson Therapeutics Announces the Appointment of Dr. Carl Bjartmar as Chief Medical Officer
HSMN NewsFeed - 21 Jul 2015
Dauntless Pharmaceuticals and Aegis Therapeutics Announce Licensing Agreement
Dauntless Pharmaceuticals and Aegis Therapeutics Announce Licensing Agreement
HSMN NewsFeed - 20 Jul 2015
BioMarin Provides Program Update for Talazoparib in Metastatic Breast Cancer
BioMarin Provides Program Update for Talazoparib in Metastatic Breast Cancer
HSMN NewsFeed - 20 Jul 2015
BioSpecifics Announces Approval of XIAFLEX(R) in Japan for the Treatment of Dupuytren's Contracture
BioSpecifics Announces Approval of XIAFLEX(R) in Japan for the Treatment of Dupuytren's Contracture
HSMN NewsFeed - 19 Jul 2015
Sorrento Announces Departure of Mr. George Uy to become CEO of Start-up Company
Sorrento Announces Departure of Mr. George Uy to become CEO of Start-up Company
